These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9495236)

  • 21. Early evaluation of an organised mammography screening program in Greece 2004-2009.
    Simou E; Tsimitselis D; Tsopanlioti M; Anastasakis I; Papatheodorou D; Kourlaba G; Gerasimos P; Maniadakis N
    Cancer Epidemiol; 2011 Aug; 35(4):375-80. PubMed ID: 21474412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A breast cancer screening programme operating in a liberal health care system: the Luxembourg Mammography Programme, 1992-1997.
    Autier P; Shannoun F; Scharpantgen A; Lux C; Back C; Severi G; Steil S; Hansen-Koenig D
    Int J Cancer; 2002 Feb; 97(6):828-32. PubMed ID: 11857363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance indicators evaluation of the population-based breast cancer screening programme in Northern Portugal using the European Guidelines.
    Bento MJ; Gonçalves G; Aguiar A; Castro C; Veloso V; Rodrigues V
    Cancer Epidemiol; 2015 Oct; 39(5):783-9. PubMed ID: 26315486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First report of introducing population-based breast cancer screening in Poland: experience of the 3-million population region of Lower Silesia.
    Matkowski R; Szynglarewicz B
    Cancer Epidemiol; 2011 Dec; 35(6):e111-5. PubMed ID: 21840281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Number and characteristics of breast cancer cases diagnosed in four periods in the screening interval of a biennial population-based screening programme.
    Hofvind S; Bjurstam N; Sørum R; Bjørndal H; Thoresen S; Skaane P
    J Med Screen; 2006; 13(4):192-6. PubMed ID: 17217608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.
    Duffy SW; Dibden A; Michalopoulos D; Offman J; Parmar D; Jenkins J; Collins B; Robson T; Scorfield S; Green K; Hall C; Liao XH; Ryan M; Johnson F; Stevens G; Kearins O; Sellars S; Patnick J
    Lancet Oncol; 2016 Jan; 17(1):109-14. PubMed ID: 26655422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seventeen-years overview of breast cancer inside and outside screening in Denmark.
    Domingo L; Jacobsen KK; von Euler-Chelpin M; Vejborg I; Schwartz W; Sala M; Lynge E
    Acta Oncol; 2013 Jan; 52(1):48-56. PubMed ID: 22943386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attending the breast screening programme after breast cancer treatment: a population-based study.
    de Munck L; Kwast A; Reiding D; de Bock GH; Otter R; Willemse PH; Siesling S
    Cancer Epidemiol; 2013 Dec; 37(6):968-72. PubMed ID: 24075800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mammography screening in the Netherlands: delay in the diagnosis of breast cancer after breast cancer screening.
    Duijm LE; Groenewoud JH; Jansen FH; Fracheboud J; van Beek M; de Koning HJ
    Br J Cancer; 2004 Nov; 91(10):1795-9. PubMed ID: 15505630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effectiveness of population-based breast cancer screening programme].
    Szynglarewicz B; Matkowski R; Kasprzak P; Kotowska J; Forgacz J; Pudełko M; Kornafel J
    Pol Merkur Lekarski; 2009 Feb; 26(152):117-20. PubMed ID: 19388515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do screen-detected breast cancers have positive margins less often than clinically detected breast cancers?
    de Munck L; Siesling S; Bart J; Menke-Pluijmers MB; Otter R; Willemse PH
    Eur J Cancer Prev; 2013 Sep; 22(5):398-403. PubMed ID: 23492953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interval cancer rates in the Irish national breast screening programme.
    O'Brien KM; Dwane F; Kelleher T; Sharp L; Comber H
    J Med Screen; 2015 Sep; 22(3):136-43. PubMed ID: 25917389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study.
    Autier P; Boniol M; Koechlin A; Pizot C; Boniol M
    BMJ; 2017 Dec; 359():j5224. PubMed ID: 29208760
    [No Abstract]   [Full Text] [Related]  

  • 35. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
    Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
    Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient and tumor characteristics of bilateral breast cancer at screening mammography in the Netherlands, a population-based study.
    Setz-Pels W; Duijm LE; Groenewoud JH; Louwman MW; Jansen FH; van Beek M; Plaisier ML; Voogd AC
    Breast Cancer Res Treat; 2011 Oct; 129(3):955-61. PubMed ID: 21553118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A decade of breast cancer screening in The Netherlands: trends in the preoperative diagnosis of breast cancer.
    Duijm LE; Groenewoud JH; Roumen RM; de Koning HJ; Plaisier ML; Fracheboud J
    Breast Cancer Res Treat; 2007 Nov; 106(1):113-9. PubMed ID: 17219049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flemish breast cancer screening programme: 15 years of key performance indicators (2002-2016).
    Goossens M; De Brabander I; De Grève J; Van Ongeval C; Martens P; Van Limbergen E; Kellen E
    BMC Cancer; 2019 Oct; 19(1):1012. PubMed ID: 31660890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Socioeconomic inequalities in attending the mass screening for breast cancer in the south of the Netherlands--associations with stage at diagnosis and survival.
    Aarts MJ; Voogd AC; Duijm LE; Coebergh JW; Louwman WJ
    Breast Cancer Res Treat; 2011 Jul; 128(2):517-25. PubMed ID: 21290176
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.